Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2017 Jan 6;2017:bcr2016218218. doi: 10.1136/bcr-2016-218218

Primary non-Hodgkin's lymphoma of the tongue: a diagnostic dilemma of unusual case presentation

Natheer Hashim Al-Rawi 1
PMCID: PMC5256451  PMID: 28062438

Abstract

Primary non-Hodgkin's lymphoma of the tongue is extremely uncommon, which makes its diagnosis quite challenging. A panel of 11 markers is used based on morphological differential diagnosis to elucidate the lymphoma subtype. A case of 43-year-old Egyptian man suffering from nodular mass on the right side of the tongue of 4 months duration is presented. No cervical lymphadenopathy was detected. No abdominal organomegaly was noted. The histological evaluation of incisional biopsy revealed a sheet of pleomorphic lymphoid cells with abnormal mitotic figures. A large number of histiocytes were infiltrating the lymphoid cellular sheet. The results of immunophenotyping were extranodal T-cell lymphoma. A proper immunohistochemical workup is crucial for the correct diagnosis and proper management.

Background

Extranodal non-Hodgkin's lymphomas (NHLs) include a diverse and complex group of solid malignant tumours with variable clinical and histopathological features. In total, 8–13% of lymphomas involve the head and neck region.1 2 Pazoki et al3 reported four cases of primary extranodal NHL of jaw bones and reviewed the literature about extranodal NHL affecting the hard tissue. Primary NHL of the tongue is extremely rare, and this makes its diagnosis quite challenging. Van der Waal et al4 in their case series analysis of 40 primary extranodal NHL of oral cavity found the most common sites involved were the palate and gingiva. Meheshwari et al5 reviewed 12 cases of tongue lymphoma. Shah et al6 in their case series analysis found alveolar bones and hard palate were the most common sites. The primary NHL of the oral cavity appear as non-tender soft or firm nodules of the area often with surface ulcerations7 which may be misdiagnosed with other oral lesions. Primary lymphoma of the tongue usually present as soft, bulky nodular mass covered by normal or ulcerated mucosa.8 We encountered a rare case of primary T-cell lymphoma of the tongue as a nodular swelling on the right side of the tongue.

Case presentation

A 43-year-old Egyptian man attended oral medicine clinic at College of Dental Medicine, University of Sharjah, UAE, with a 4 months history of slow growth of nodular mass on the right side of the tongue. The patient was heavy smoker and regular alcohol drinker. He had negative history of neck mass, febrile illnesses, weight loss and night sweats. The oral lesion presented as a 3×3 cm nodular mass involving the middle portion of the right side of the tongue. The deep central groove of the tongue separates the mass from the rest of the tongue (figure 1). The movement of the tongue was normal. The right pharyngeal wall and the tonsils were normal. No cervical lymphadenopathy was detected. No abdominal organomegaly was noted on CT scan. The patient underwent surgery for an incisional biopsy. The histological evaluation revealed a sheet of pleomorphic lymphoid cells and abnormal mitotic figures. A large number of histiocytes were infiltrating the lymphoid cellular sheet (figure 2).

Figure 1.

Figure 1

The 3×3 cm nodular mass is seen at presentation.

Figure 2.

Figure 2

Histological sections show the atypical lymphocytes with abnormal mitotic figures (arrows) with macrophages infiltrates (H&E, original magnification ×400).

Investigations

To differentiate between lymphoma subtypes, immunohistochemistry was performed for proliferation (Ki67), PAN-T (CD3), B-cell antigen (CD20), leucosialin (CD43), granzyme B, CD68, CD4, CD8, CD30, CD56 and ALK to confirm the diagnosis which was extranodal T-cell lymphoma. Figure 3A–F revealed strong to mild expression against Ki67, CD3, CD20, CD43, granzyme B and CD68. However, figure 4A–E demonstrates weak to negative expression against CD4, CD8, CD30, CD56 and Alk1 (CD246).

Figure 3.

Figure 3

Immunophenotyping demonstrates strong reaction against Ki67 (A), CD3 (B) and CD43 (C); moderate reaction with granzyme B (D) and CD68 (E); and mild reaction with CD20 (F).

Figure 4.

Figure 4

Immunophenotyping demonstrate weak or negative reaction against CD4 (A), CD8 (B), CD30 (C), CD56 (D) and Alk1 (E).

Differential diagnosis

  • B-cell lymphoma

  • T-cell lymphoma

  • Natural killer (NK)-cell lymphoma

  • Histiocytic lymphoma

Outcome and follow-up

The patient was staged as Ann Arbour stage IE and referred to oncology clinic to start CHOP chemotherapy (cyclophosphamide, hydroxydaunomycin, oncovin, prednisolone) followed by radiotherapy. The results of immunophenotyping are depicted in table 1.

Table 1.

Immunohistochemical markers used for the case

Marker Ki67 CD3 CD20 CD43 Gran B CD68 CD4 CD8 CD30 CD56 CD246
Present case + + − (+) + + (−) − (+) − (+)
T-cell lymphoma + + + − (+) − (+) − (+) − (+)
B-cell lymphoma + + − (+) − (+) Variable
NK-cell/T-cell lymphoma + (cytoplasm −; membrane +) + + − (+) + +

NK, natural killer.

Discussion

NHLs are a group of highly diverse malignant cells that tend to affect organs and tissues that are not ordinarily composed of lymphoid cells. WHO classifies peripheral tumours of lymphoid tissues as B-cell lymphoma, T-cell lymphoma, peripheral T-cell/NK-cell lymphoma and peripheral T-cell lymphoma, and NOS (not otherwise specified). Extranodal NHLs constitute about 20–30% of NHLs.8 The head and neck is the second most common site for extranodal lymphomas after the gastrointestinal tract.9 Waldyer's ring lymphomas are the most common area of malignant lymphoma.1 The intraoral location is not common; it comprises only 2% of all extranodal lymphomas.10 11 Tonsils and palate are the most frequent sites.8 Epstein et al12 in 2001 reported 361 cases in the oral and perioral region; they found that the most common sites were tonsils (118 cases; 32.6%), parotid gland (58 cases;16%) and then nasopharynx (40 cases; 11%). Most intraoral lymphomas were of large cell types (137 cases; 38%), followed by small cell type (99 cases; 27.4%) and then lymphoma NOS (82 cases; 22.7%). Kemp et al13 in 2008 reported 40 cases of NHL; maxilla was the most common site (27.5%) and the most common clinical presentation was swelling and ulceration. Guevara-Canales et al14 in their systematic review of 714 patients from 1990 to 2010 found that Waldeyer's ring was the most frequent extraoral site, whereas gingiva was the most frequent intraoral site. The predisposing factors of oral NHLs have not been identified yet, although few cases have reported an association with HIV infection.1 2 Oral NHLs have similar clinical appearance of a more commonly benign oral lesions.15 Thus, these lesions may be easily misdiagnosed. Lymphomas and more commonly carcinomas could not be differentiated clinically; therefore, awareness of this clinical entity inside the mouth is very important. The tongue itself is an extremely unusual site for isolated primary NHL.16 17 Few cases reported primary extranodal NHL of the tongue though most of them presented as submucosal mass with no ulceration.18–20 Of these, only two cases presented without cervical lymph nodes involvement.19 20 The case presented in this paper involved one side of the tongue with deep central fissure separating the mass from normal tissue with no cervical lymph nodes involvement. Inchingolo et al21 reported an unusual case of NHL of tongue in a 73-year-old man involving the whole tongue with enlarged subcranial and right pulmonary hilar lymph nodes. Tongue lymphoma could be easily mistaken for hypertrophic lingual tonsil, benign neoplasms like peripheral nerve sheath tumours, benign salivary gland tumours, leiomyoma and rhabdomyosarcoma, beside infective processes such as tongue abscess, fungal infection and bite-related trauma could have been possible differentials. According to Colmenero et al,22 intraoral lymphomas first signs may appear as infection in 50% of cases. Asymptomatic soft swelling with or without ulceration might be seen when tonsils, palate, buccal mucosa, gum, tongue and floor of mouth were involved.23 Alveolar bone loss with oedema and pain has been reported which often mimics periodontal disease.24 Lip paraesthesia and pathological fracture may be reported as a common sign of jaw involvement.25 On histology, these tumours typically demonstrated a mixture of pleomorphic malignant T cells with few reactive cells infiltrate, such as eosinophil and histiocytes.Tongue lymphomas are usually made of B-cell origin.1 8 The patient's tumour of the presented case was of the T-cell type as confirmed by immunohistochemical phenotyping. Immunohistochemistry is almost compulsory for the correct diagnosis and characterisation of immunophenotype in most of the lymphomas. A panel of 11 markers is decided based on morphological differential diagnosis. The cells expressed high Ki67 labelling index, more than 90% of atypical cells were positive against this antigen. This indicates a bad clinical course of the disease.26 PAN-T marker (CD3) and B-lymphocyte antigen (CD20) were used27 to distinguish between B-cell and T-cell variants. More than 90% of malignant cells examined in this case were positive for CD3 marker and <25% of cells were positive for CD-20. Leucosialin (sialophorin) immunohistochemical marker which is a major sialoglycoprotein on the surface of human T lymphocytes was positive over 90% of T-cell lymphoma.28 Isaccson et al29 used CD20+ (a PAN-B-cell marker) and CD3− (a PAN-T-cell marker) to profile extranodal follicular lymphomas of the head and neck region. Granzyme B was used to discriminate between T and NK cells.30 Nearly 50% of malignant cells of the present case were granzyme B positive. In the present case, histiocytes were infiltrating the lymphoid cellular sheet; therefore, CD68 was used to distinguish between malignant histiocytosis and histiocytic lymphoma.10 The atypical cells of the present case were positive in <50% of cells. The increase in tumour-associated macrophages is usually related to the high proliferative index of the tumour.31 CD4 and CD8 were always negative in cases of extranodal NK-cell/T-cell lymphoma especially in nasal type. Both markers were also negative in the studied case. NK cells and activated T cells were always positive for CD56. However, this marker was negative in the present case. This eliminates the presence of NK cells in the case studies. The present case was also negative for CD30 and CD246, which eliminates the probable diagnosis of anaplastic large cell lymphoma.32–34 NHLs are very responsive to radiation and chemotherapy therefore, differentiating this lesion from carcinoma is very crucial for proper management.2 8

Conclusion

Primary NHL of the tongue is a rare disease entity particularly of T-cell type. It usually misdiagnosed as squamous cell carcinoma clinically. Therefore, this possibility should be kept in mind when diagnosing benign and malignant lesions of this area. A proper diagnostic assessment with adequate immunohistochemical phenotyping like (PAN-T, PAN-B, CD3, CD20, etc) are essential to confirm diagnosis and improve management and long-term survival. Differentiating NHL from carcinoma is critical for treatment of these lesions, since NHLs are highly sensitive to radiotherapy and chemotherapy.5 The prognosis of patients with extranodal NHLs mainly depends on the tumour stage, tumour grade and aggressiveness beside patient's response to treatment.

Learning points.

  • Primary non-Hodgkin's lymphoma (NHL) of the tongue is extremely uncommon, which makes its diagnosis quite challenging.

  • Differentiating a NHL from other reactive or malignant oral lesions is critical for the management of these lesions.

  • A proper immunohistochemical workup is necessary for the correct diagnosis and proper management.

Footnotes

Competing interests: None declared.

Patient consent: Obtained.

Provenance and peer review: Not commissioned; externally peer reviewed.

References

  • 1.Vaswani B, Shah M, Shah PM. Non Hodgkin's lymphoma of tongue—a case report. Ind J Med Pediat Oncol 2008;29:59–61. [Google Scholar]
  • 2.Mehshwari GK, Baboo HA, Shah NM. Primary non-Hodgkin's lymphoma of the oral tongue. Turk J Cancer 2001;31:121–4. [Google Scholar]
  • 3.Pazoki A, Jansisyanont P, Ord RA. Primary non-Hodgkin's lymphoma of the jaws: report of 4 cases and review of the literature. J Oral Maxillofac Surg 2003;61:112–17. 10.1053/joms.2003.50018 [DOI] [PubMed] [Google Scholar]
  • 4.Van der Waal RI, Huijgens PC, Van der Valk P et al. Characteristics of 40 primary extranodal non-Hodgkin's lymphomas of the oral cavity in perspective of the new WHO classification and the International Prognostic Index. Int J Oral Maxillofac Surg 2005;34:391–5. 10.1016/j.ijom.2004.08.009 [DOI] [PubMed] [Google Scholar]
  • 5.Maheshwari GK, Baboo HA, Gopal U et al. Primary extra-nodal non-Hodgkin's lymphoma of the cheek. J Postgrad Med 2000;46:211–12. [PubMed] [Google Scholar]
  • 6.Shah GH, Panwar SK, Chaturvedi PP et al. Isolated primary extranodal lymphoma of the oral cavity: a series of 15 cases and review of literatures for a tertiary care center in India. Ind J Med Ped Oncol 2011;32:76–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ramani P, Ahmed S, Janaki VR. Primary non-Hodgkin's lymphoma of the oral cavity. Ind J Dematol Venereol Leprol 2004;70:172–4. [PubMed] [Google Scholar]
  • 8.Hanna E, Wanamaker J, Adelstein D et al. Extranodal lymphomas of the head and neck. A 20-year experience. Arch Otolaryngol Head Neck Surg 1997;123:1318–23. [DOI] [PubMed] [Google Scholar]
  • 9.Sutcliffe SB, Gospodarowicz MK. Localized extranodal lymphomas. In: Keating A, Armitage J, Bennett A et al. Hematological oncology. Cambridge, England: Cambridge University Press, 1992:189–222. [Google Scholar]
  • 10.Segami N, Hosoda M, Fukuda M et al. Adult T-cell leukemia/lymphoma of the tongue. Oral Surg Oral Med Oral Pathol 1990;70:206–9. [DOI] [PubMed] [Google Scholar]
  • 11.Kobler P, Borcic J, Filipovic ZI et al. Primary non-Hodgkin's lymphoma of the oral cavity. Oral Oncol Extra 2005;41:12–14. [Google Scholar]
  • 12.Epstein JB, Epstien JD, Le ND et al. Characterization of oral and parapral malignant lymphoma: a population-based review of 361 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:519–25. 10.1067/moe.2001.116062 [DOI] [PubMed] [Google Scholar]
  • 13.Kemp S, Gallagher G, Kabani S et al. Oral non-Hodgkin's lymphoma: review of the literature and World health Organization classification with reference to 40 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:194–201. 10.1016/j.tripleo.2007.02.019 [DOI] [PubMed] [Google Scholar]
  • 14.Guevara-Canales JO, Moralies-Vadillo R, De Faria PE et al. Systematic review of lymphoma in oral cavity and maxillofacial region. Acta Odontol Latinoam 2011;24:245–51. [PubMed] [Google Scholar]
  • 15.Wilson TG, Wright JM. Non-Hodgkin's lymphoma of the gingiva: a review of the literature. Report of a case. J Periodontal 1986;57:155–7. [DOI] [PubMed] [Google Scholar]
  • 16.Van der Waal RI, Pas HH, Anhalt GJ et al. Paraneoplastic pemphigus as the presenting symptom of a lymphoma of the tongue. Oral Oncol 1998;34:567–70. [DOI] [PubMed] [Google Scholar]
  • 17.Zapater E, Bagan JV, Carbonell F et al. Malignant lymphoma of the head and neck. Oral Dis 2010;16:119–28. 10.1111/j.1601-0825.2009.01586.x [DOI] [PubMed] [Google Scholar]
  • 18.Yaris N, Kutluk T, Akcoren Z et al. Primary non-Hodgkin's lymphoma in a child [letter]. Med Pediatr Oncol 1998;43:422–4. [DOI] [PubMed] [Google Scholar]
  • 19.Benjamin I. Histiocytic lymphoma (reticulum cell sarcoma) of the tongue manifesting as macroglossia. Hum Pathol 1983;14:375–7. [DOI] [PubMed] [Google Scholar]
  • 20.Derk CT, Conway RT, Jimenez SA. Primary B-cell lymphoma of the tongue in a patient with systemic sclerosis. Oral Oncol 2004;40:103–6. [DOI] [PubMed] [Google Scholar]
  • 21.Inchingolo F, Tatullo M, Abenavoli FM et al. Non-Hodgkin lymphoma affecting the tongue: unusual intra-oral location. Head Neck Oncol 2011;3:1 10.1186/1758-3284-3-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Colmenero C, Gamalo C, Pintado V et al. AIDS-related lymphoma of the oral cavity. Int J Oral Maxillofac Surg 1991;20:2–6. [DOI] [PubMed] [Google Scholar]
  • 23.Ardekian L, Rachmiel A, Rosen D et al. Burkitt's lymphoma oh the oral cavity in Israel. J Craniomaxillofac Surg 1999;27:294–7. [DOI] [PubMed] [Google Scholar]
  • 24.Farias JG. Linfoma não-hodgkin de células B: relato de caso. Rev Cir Traumatol Bucomaxilofac 2008;8:25–30. [Google Scholar]
  • 25.Solomides CC, Miller AS, Christman RA et al. Lymphomas of the oral cavity: histology immunologic type, and incidence of Epstein-Barr virus infection. Hum Pathol 2002;33:153–7. [DOI] [PubMed] [Google Scholar]
  • 26.Sholzen T, Gerdes J. The Ki-67 protein from the known and the unknown. J Cell Physiol 2000;182:311–22. 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9 [DOI] [PubMed] [Google Scholar]
  • 27.Campbell SM, Peters SB, Zirwas MJ et al. Immunophenotypic diagnosis of primary cutaneous lymphomas. A review for the practicing dermatologist. J Clin Anesth Dermatol 2010;3:21–5. [PMC free article] [PubMed] [Google Scholar]
  • 28.Fernandez-Rodriguez J, Andersson CX, Laos S et al. The leukocyte antigen CD43 is expressed in different cell lines of nonhematopoietic origin. Tumour Biol 2002;23:193–201. doi:67252 [DOI] [PubMed] [Google Scholar]
  • 29.Isaccson P, Wright DH. Malignant lymphoma of mucosa associated lymphoid tissue: a distinctive type of B-cell lymphoma. Cancer 1983;52:1410–16. [DOI] [PubMed] [Google Scholar]
  • 30.Cho MS, Lee MK, Yang WI et al. Granzyme B immunoreactivity in T/natural killer cell lymphomas. Yonsei Med J 1997;38:285–93. 10.3349/ymj.1997.38.5.285 [DOI] [PubMed] [Google Scholar]
  • 31.Liu Y, Fan L, Wang Y et al. Tumor-associated macrophages promote tumor cell proliferation in nasopharyngeal NK/T-cell lymphoma. Int J Clin Exp Pathol 2014;7:5429–35. [PMC free article] [PubMed] [Google Scholar]
  • 32.Paulli M, Boveri E, Rosso R et al. CD56/neural cell adhesion molecule expression in primary extranodal Ki-1/CD30+ lymphoma. Report of a pediatric case with simultaneous cutaneous and bone localizations. Am J Dermatopathol 1997;19:384–90. [DOI] [PubMed] [Google Scholar]
  • 33.Ferreri AJ, Govi S, Pileri SA et al. Anaplastic large cell lymphoma, ALK-positive. Crit Rev Oncol Hematol 2012;83:293–302. 10.1016/j.critrevonc.2012.02.005 [DOI] [PubMed] [Google Scholar]
  • 34.Gorczyca W, Tsang P, Liu Z et al. CD30-positive T-cell lymphomas co expressing CD15: an Immunohistochemical analysis. Int J Oncol 2003;22:319–24. [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES